Novo launched a rival bid to acquire American obesity biotech firm Metsera last week, superseding an offer for the firm from ...

The lowest doses of Eli Lilly’s Zepbound and Novo Nordisk's Wegovy could be available for as little as $149 a month.

Novo Nordisk, as well as Eli Lilly, would gain Medicare and Medicaid coverage for their blockbuster weight-loss drugs.

Such conversations are becoming increasingly common as demand for weight-loss drugs explodes in urban India - a country with ...

Obesity drugs have become an increasingly popular method of weight loss but most are not covered by insurance for that ...

There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle ...

It seems a number of people who are using both Botox and weight loss jabs at the same time are complaining about the same ...

But does starting Ozempic really throw off birth control? “I'm not aware of any publications that actually report changes in pregnancy rates themselves,” says Jessica Skelley, a pharmacist at Samford ...

The kilo-shedding jabs can lead to ‘Ozempic face’ and make you look gaunt. Experts reveal how to minimise your risk and ...

The hospitality industry is feeling the effects of the weight-loss jab boom. With 2.5 million people in the UK now using ...